David E Granstrom

Title: Innovations of David E Granstrom in Equine Health

Introduction

David E Granstrom is a notable inventor based in Lexington, KY (US), recognized for his contributions to equine health through innovative diagnostic and treatment methods. He holds two patents that focus on addressing the challenges posed by Sarcocystis neurona, a protozoan responsible for equine protozoal myelitis (EPM).

Latest Patents

Granstrom's latest patents include a diagnostic primer for Sarcocystis neurona and formulations for treating and preventing EPM. The first patent describes an amplification primer and probe that can be utilized in an in vitro diagnostic test to detect the presence of S. neurona in equine blood or cerebrospinal fluid. This primer is specifically designed to target a unique section of the small ribosomal subunit of Sarcocystis neurona, encompassing nucleotide positions 1470-1487. The primer sequence is 5' CCATTCCGGACGCGGGT SEQ ID NO:1. The second patent provides formulations and methods to treat EPM, recommending the use of triazine-based anti-coccidials such as clazuril, diclazuril, toltrazuril, or letrazuril for effective treatment and prevention of S. neurona infection in horses.

Career Highlights

Granstrom is affiliated with the University of Kentucky Research Foundation, where he has made significant strides in equine health research. His work has been instrumental in developing diagnostic tools and treatment methods that enhance the well-being of horses affected by protozoal infections.

Collaborations

Throughout his career, Granstrom has collaborated with esteemed colleagues such as Thomas Tobin and Clara K Fenger, contributing to advancements in veterinary medicine and research.

Conclusion

David E Granstrom's innovative work in the field of equine health has led to significant advancements in the diagnosis and treatment of protozoal infections. His contributions continue to impact the veterinary community positively.